Advertisement

Document › Details
Immunicum AB. (10/16/18). "Press Release: Immunicum AB (publ) Clarifies Information Regarding Directed Issue [Not for US, AU, CA, et al.]".
Original document
accessed by [iito] on 2018-10-16
Record changed: 2018-10-20 |
Advertisement

More documents for Immunicum AB (publ) (Nasdaq Stockholm: IMMU.ST)
- [1] Immunicum AB. (10/16/18). "Press Release: Notice of Extraordinary General Meeting in Immunicum AB (publ)"....
- [2] Immunicum AB. (10/16/18). "Press Release: Immunicum AB (publ) Raises SEK 351M in a Directed Issue and a Fully Guaranteed Rights Issue for Continued Clinical Development of Ilixadencel - a New and Innovative Cancer Immunotherapy [Not for US, AU, CA, et al...
- [3] Immunicum AB. (9/27/18). "Press Release: Immunicum AB (publ) Announces Upcoming Presentations at Conferences in October"....
- [4] Immunicum AB. (1/31/18). "Press Release: Michaela Gertz Joins Immunicum as CFO"....
- [5] Immunicum AB. (1/15/18). "Press Release: Immunicum AB (publ) Initiates Trading of Shares on Nasdaq Stockholm"....
- [6] Immunicum AB. (12/29/17). "Press Release: Immunicum AB (publ) Announces the Outcome of the Rights Issue [Not for US, AU, CA, et al.]"....
- [7] Immunicum AB. (8/22/17). "Press Release: Immunicum AB (publ) Announces Upcoming Presentations at Conferences in August and September"....
- [8] Immunicum AB. (8/18/17). "Press Release: Interim Report Q2 – Corporate Update and Outlook"....
- [9] Immunicum AB. (8/17/17). "Press Release: Immunicum Completes Strategic Analysis and Defines Updated Clinical Development Plan for Ilixadencel"....
- [10] Immunicum AB. (5/19/17). "Press Release: Quarterly Report January-March 2017"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top